Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ENO1 | P06733 | 1/20 | 0.45 |
| ▸ | CETP | P11597 | 3/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | PTPRC | P08575 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10378803 | 1.00 | ALDH1A1 (0.49) | ALDH1A1TSHRENO1CETPPRKCA | |
| SCHEMBL16093681 | 0.87 | TSHR (0.63) | ALDH1A1TSHRENO1CETPPRKCA | |
| SCHEMBL19509036 | 0.83 | ALDH1A1 (0.61) | ALDH1A1TSHRCETPFOLH1LMNA | |
| SCHEMBL3804139 | 0.83 | TSHR (0.59) | ALDH1A1TSHRCETPFOLH1LMNA | |
| SCHEMBL3804138 | 0.83 | TSHR (0.55) | ALDH1A1TSHRCETPFOLH1LMNA | |
| SCHEMBL10379906 | 0.81 | ALDH1A1 (0.50) | ALDH1A1ENO1LMNABTN3A1L3MBTL1 | |
| SCHEMBL13347322 | 0.81 | TSHR (0.49) | ALDH1A1TSHRCETPFOLH1LMNA | |
| SCHEMBL10378800 | 0.80 | BTN3A1 (0.50) | ALDH1A1TSHRENO1PRKCABTN3A1 | |
| SCHEMBL21189480 | 0.80 | TSHR (0.51) | ALDH1A1TSHRCETPFOLH1LMNA | |
| SCHEMBL3072372 | 0.80 | ALDH1A1 (0.61) | ALDH1A1TSHRCETPFOLH1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190224220-A1 | Carbidopa and L-Dopa Prodrugs and Methods of Use | ABBVIE INC. (US) | 2019-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190224220-A1 | Carbidopa and L-Dopa Prodrugs and Methods of Use | COMT, SNCA, PARK7 | ALDH1A1 694/4885TSHR 1816/4885ENO1 2608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.